+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Digoxin"

From
Inotropic Agents Market Report 2025 - Product Thumbnail Image

Inotropic Agents Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Management of Heart Failure. Edition No. 1 - Product Thumbnail Image

Management of Heart Failure. Edition No. 1

  • Book
  • October 2010
  • 408 Pages
  • 9 Results (Page 1 of 1)
Loading Indicator

Digoxin is a cardiac glycoside used to treat heart failure and atrial fibrillation. It is also used to control ventricular rate in supraventricular tachycardia. Digoxin is a part of the cardiovascular drug market, which includes drugs used to treat heart failure, hypertension, and other cardiovascular diseases. Digoxin is used to treat heart failure by increasing the force of contraction of the heart muscle, which helps the heart pump more efficiently. It is also used to treat atrial fibrillation by slowing the ventricular rate and helping to maintain normal sinus rhythm. Digoxin is available in both oral and injectable forms. It is available as a generic drug and is also sold under the brand names Lanoxin and Digitek. Digoxin is available in a variety of strengths and formulations, including tablets, capsules, and injectable solutions. Companies in the Digoxin market include GlaxoSmithKline, Pfizer, Sanofi, Mylan, and Teva Pharmaceuticals. Show Less Read more